Surfactant: Current and potential therapeutic application in infants and adults

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 9, Issue 1, 1996, Pages 143-154

  Lewis, Jim ^a,b   Veldhuizen, Ruud A W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

acute lung injury; ARDS; surfactant supplementation

Indexed keywords

LUNG SURFACTANT; SURFACTANT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; DOSE RESPONSE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; RESPIRATORY DISTRESS SYNDROME; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0029892091     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1996.9.143     Document Type: Review

References (43)

1. ANZUETO, A., BAUGHMAN, R., GUNTUPALLI, K., DEMARIA, E., DAVIS, K., WEG, J., LONG, W., HORTON, J., and PATTISHALL, E. (1994). An international, randomized, placebo-controlled trial evaluating the safety and efficacy of aerosolized surfactant in patients with sepsis-induced ARDS. Am. J. Respir. Crit. Care Med. 149 (Suppl. PT 2 of 2):A567.
2. BAUGHMAN, R.P., STERNBERG, R.I., HULL, W., BUCHSBAUM, J.A., and WHITSETT, J. (1993). Decreased surfactant protein A in patients with bacterial pneumonia. Am. Rev. Respir. Dis. 147:653-657.
3. DUNN, M.S., SHENNAN, A.T., ZAYACK, D., and POSSMAYER, F. (1991). Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: A randomized controlled trial of prophylaxis versus treatment. Pediatrics 87:377-386.
4. ENHORNING, G., and HOLM, B.A. (1993). Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. J. Appl. Physiol. 74:2922-2927.
5. ERASMUS, M.E., PETERSEN, A.H., OETOMO, S.B., and PROP, J. (1994). The function of surfactant is impaired during the reimplantation response in rat lung transplants. J. Heart Lung Transplant. 13:791-802.
6. GREGORY, T.J., LONGMORE, W.J., MOXLEY, M.A., WHITSETT, J.A., REED, C.R., FOWLER, A.A., MAUNDER, R.J., CRIM, C., and HYERS, T.M. (1991). Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88:1976-1981.
7. GREGORY, T.J., GADEK, J.E., WEILAND, J.E., HYERS, T.M., CRIM, C., HUDSON, L.D., STEINBERG, K.P., MAUNDER, R.A., SPRAGG, R.G., SMITH, R.M., TIERNEY, D.F., GIPE, B., LONGMORE, W.J., and MOXLEY, M.A. (1994a). Survanta supplementation in patients with acute respiratory distress syndrome (ARDS). Am. J. Respir. Crit. Care Med. 149(Suppl. PT 2 of 2):A567.
8. GREGORY, T.J., LONGMORE, W.J., MOXLEY, M.A., CAI, G.-Z., GADEK, J.E., WEILAND, J.E., HYERS, T.M., CRIM, C., HUDSON, L.D., STEINBERG, K.P., MAUNDER, R.A., SPRAGG, R.G., SMITH, R.M., TIERNEY, D.F., and GIPE, B. (1994b). Surfactant repletion following Survanta supplementation in patients with acute respiratory distress syndrome (ARDS). Am. J. Respir. Crit. Care Med. 149(Suppl. PT. 2 of 2):A124.
9. HALL, S.B., HYDE, R.W., and NOTTER, R.H. (1994). Changes in subphase aggregates in rabbits injured by free fatty acid. Am. J. Respir. Crit. Care Med. 149:1099-1106.
10. HALLMAN, M., MAASILTA, P., SIPILA, I., and TAHVANAINEN, J. (1989). Composition and function of pulmonary surfactant in adult respiratory distress syndrome. Eur. Respir. J. Suppl. 3:104s-108s.
11. HOLM, B.A. (1992). Surfactant inactivation in adult respiratory distress syndrome. In B. Robertson, L.M.G. Van Golde, and J.J. Batenburg, eds. Pulmonary Surfactant: From Molecular Biology to Clinical Practice. Elsevier, Amsterdam, 665-684.
12. ITO, Y., GOFFIN, J., VELDHUIZEN, R., JOSEPH, M., BJARNESON, D., McCAIG, L., YAO, L-J., MARCOU, J., and LEWIS, J. (1995). Timing of exogenous surfactant administration in a rabbit model of acute lung injury. J. Appl. Physiol. (in press).
13. KAKUTA, Y., SASAKI, H., and TAKISHIMA, T. (1991), Effect of artificial surfactant on ciliary beat frequency in guinea pig trachea. Respir. Physiol. 83:313-321.
14. KATTWINKEL, J., BLOOM, B.T., DELMORE, P., DAVIS, C.L., FARRELL, E., FRISS, H., JUNG, A.L., KING, K., and MUELLER, D. (1993). Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation [see comments]. Pediatrics 92:90-98.
15. LACHMANN, B. (1989a). Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome. Eur. Respir. J. Suppl. 3:98s-103s.
16. LACHMANN, B. (1989b). Animal studies of surfactant replacement therapy. Dev. Pharmacol Ther. 13:164-172.
17. LEWIS, J., IKEGAMI, M., HIGUCHI, R., JOBE, A., and ABSOLOM, D. (1991). Nebulized vs. instilled exogenous surfactant in an adult lung injury model. J. Appl. Physiol. 71:1270-1276.
18. LEWIS, J.F., and JOBE, A.H. (1993). Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147:218-233.
19. LEWIS, J.F., and McCAIG, L.A. (1993). Aerosolized versus instilled exogenenous surfactant in a nonuniform pattern of lung injury. Am. Rev. Respir. Dis. 148:1187-1193.
20. LEWIS, J.F., IKEGAMI, M., and JOBE, A.M. (1990). Altered surfactant function and metabolism in rabbits with acute lung injury. J. Appl. Physiol. 69:2303-2310.
21. LEWIS, J.F., IKEGAMI, M., JOBE, A.H., and ABSOLOM, D. (1993a). Physiologic responses and distribution of aerosolized surfactant (Survanta) in a nonuniform pattern of lung injury. Am. Rev. Respir. Dis. 147:1364-1370.
22. LEWIS, J.F., TABOR, B., IKEGAMI, M., JOBE, A.H., JOSEPH, M., and ABSOLOM, D. (1993b). Lung function and surfactant distribution in saline lavaged sheep given instilled vs. nebulized surfactant. J. Appl. Physiol. 74:1256-1264.
23. LEWIS, J.F., GOFFIN, J., YUE, P., McCAIG, L.A., BJARNESON, D., and VELDHUIZEN, R.A.W. (1995). Evaluation of treatment strategies exogenous surfactant in an adult model of acute lung injury. J. Appl. Physiol. (in press).
24. McFADDEN, R.G., BORRON, P., FRAHER, L.J., LEWIS, J.F., and POSSMAYER, F. (1994). Pulmonary surfactant protein-A alters in vitro human lymphocyte proliferation and cytokine production. Am. J. Respir. Crit. Care Med. 149(4):A679.
25. NICHOLAS, T.E., POWER, J.H.T., and BARR, H.A. (1982). Surfactant homeostasis in the rat lung during swimming exercise. J. Appl. Physiol. 53:1521-1528.
26. NICHOLAS, T.E., POWER, J.H., and BARR, H.A. (1990). Effect of pattern of breathing on subfractions of surfactant in tissue and alveolar compartments of the adult rat lung. Am. J. Respir. Cell Mol. Biol. 3:251-258.
27. NOSAKA, S., SAKAI, T., YONEKURA, M., and YOSHIKAWA, K. (1990). Surfactant for adults with respiratory failure [letter]. Lancet 336:947-948.
28. NOVICK, R., MACDONALD, J., POSSMAYER, F., BJARNESON, D., VELDHUIZEN, R., GILPIN, A., and LEWIS, J. (1995). Combine donor and recipient bovine lipid extract surfactant (bLES) therapy can restore the function of lung grafts preserved for 38 hours. Am. J. Respir. Crit. Care Med. 151:A87 (Abstract).
29. PHELPS, D.S., and ROSE, R.M. (1991). Increased recovery of surfactant protein A in AIDS-related pneumonia. Am. Rev. Respir. Dis. 143:1072-1075.
30. PISON, U., GONO, E., JOKA, T., and OBERTACKE, U. (1987). Phospholipid lung profile in adult respiratory distress syndrome - evidence for surfactant abnormality. Prog. Clin. Biol. Res. 236A:517-523.
31. PISON, U., MAX, M., NEUENDANK, A., WEISSBACH, S., and PIETSCHMANN, S. (1994). Host defence capacities of pulmonary surfactant: Evidence for 'non-surfactant' functions of the surfactant system. Eur. J. Clin. Invest. 24:586-599.
32. POSSMAYER, F. (1988). A proposed nomenclature for pulmonary surfactant-associated proteins. Am. Rev. Respir. Dis. 138:990-998.
33. POSSMAYER, F., YU, S.H., WEBER, J.M., and HARDING, P.G. (1984). Pulmonary surfactant. Can. J. Biochem. Cell Biol. 62:1121-1133.
34. SPRAGG, R.G., GILLIARD, N., RICHMAN, P., SMITH, R.M., HITE, R.D., PAPPERT, D., ROBERTSON, B., CURSTEDT, T., and STRAYER, D. (1994). Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 105:195-202.
35. TASHIRO, K., LI, W.Z., YAMADA, K., MATSUMOTO, Y., and KOBAYASHI, T. (1995). Surfactant replacement reverse respiratory failure induced by intratracheal endotoxin in rats. Crit. Care Med. 23:149-156.
36. THOMASSEN, M.J., MEEKER, D.P., ANTAL, J.M., CONNORS, M.J., and WIEDEMANN, H.P. (1992). Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 7:257-260.
37. VAN IWAARDEN, F., WELMERS, B., VERHOEF, J., HAAGSMAN, H.P., and VAN GOLDE, L.M. (1990). Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 2:91-98.
38. VAN IWAARDEN, J.F., VAN STRIJP, J.A., EBSKAMP, M.J., WELMERS, A.C., VERHOEF, J., and VAN GOLDE, L.M. (1991). Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am. J. Physiol. 261:L204-L209.
39. VELDHUIZEN, R.A., LEE, J., SANDLER, D., HULL, W., WHITSETT, J.A., LEWIS, J., POSSMAYER, F., and NOVICK, R.J. (1993). Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. Am. Rev. Respir. Dis. 148:208-215.
40. VELDHUIZEN, R.A.W., McCAIG, L., AKINO, T., and LEWIS, J.F. (1995). Pulmonary surfactant subfractions in patients with acute respiratory distress syndrome (ARDS). Am. J. Respir. Crit. Care Med. 152(6): 1867-1871.
41. WRIGHT, J.R., and DOBBS, L.G. (1991). Regulation of pulmonary surfactant secretion and clearance. Annu. Rev. Physiol. 53:395-414.
42. WRIGHT, J.R., and HAWGOOD, S. (1989). Pulmonary surfactant metabolism. Clin. Chest Med. 10:83-93.
43. YAMADA, T., IKEGAMI, M., and JOBE, A.H. (1990). Effects of surfactant subfractions on preterm rabbit lung function. Pediatr. Res. 27:592-598.